Expression of hepatocyte growth factor and c-MET in skull base chordoma (Q33272962)

25 July 2017

title

Expression of hepatocyte growth factor and c-MET in skull base chordoma (English)

1 reference

25 July 2017

0 references

0 references

1 reference

7

0 references

Carsten Boltze

3

0 references

author name string

Takahiko Naka

1

1 reference

25 July 2017

Doerthe Kuester

2

1 reference

25 July 2017

Stefanie Scheil-Bertram

4

1 reference

25 July 2017

Amir Samii

5

1 reference

25 July 2017

Christian Herold

6

1 reference

25 July 2017

Sabine Krueger

8

1 reference

25 July 2017

Albert Roessner

9

1 reference

25 July 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

25 July 2017

1 reference

25 July 2017

volume

112

1 reference

25 July 2017

issue

1

1 reference

25 July 2017

page(s)

104-110

1 reference

Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

Expression of matrix metalloproteinases in invasive pulmonary adenocarcinoma with bronchioloalveolar component and atypical adenomatous hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

Scatter factor is a fibroblast-derived modulator of epithelial cell mobility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

7 January 2021

Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

7 January 2021

Molecular cloning and expression of human hepatocyte growth factor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

7 January 2021

Hepatocyte growth factor is a potent stimulator of human melanocyte DNA synthesis and growth

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

7 January 2021

A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

7 January 2021

Hepatocyte growth factor/hepatopoietin A stimulates the growth of rat kidney proximal tubule epithelial cells (RPTE), rat nonparenchymal liver cells, human melanoma cells, mouse keratinocytes and stimulates anchorage-independent growth of SV-40 tran

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

7 January 2021

Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

7 January 2021

The met proto-oncogene receptor and lumen formation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

7 January 2021

Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

7 January 2021

Production of hepatocyte growth factor by human haematopoietic cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

7 January 2021

The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

7 January 2021

Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

7 January 2021

Mechanism of met oncogene activation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

7 January 2021

Molecular cloning of a new transforming gene from a chemically transformed human cell line.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

7 January 2021

Expression of scatter factor and c-met receptor in benign and malignant breast tissue

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

7 January 2021

Frequent amplification of the c-met gene in scirrhous type stomach cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

7 January 2021

c-met proto-oncogene expression in benign and malignant human prostate tissues

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

7 January 2021

Comparison of histological changes and changes in nm23 and c-MET expression between primary and metastatic sites in osteosarcoma: a clinicopathologic and immunohistochemical study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

7 January 2021

Expression of Met protein in thyroid tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

7 January 2021

Immunohistochemical demonstration of MET overexpression in human intrahepatic cholangiocarcinoma and in hepatolithiasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

7 January 2021

c-met tyrosine kinase receptor expression is associated with abnormal beta-catenin expression and favourable prognostic factors in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

7 January 2021

c-erbB-2 and c-Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

7 January 2021

Differential expression of epidermal growth factor receptor, c-Met, and HER2/neu in chordoma compared with 17 other malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

7 January 2021

Base of skull chordoma. A correlative study of histologic and clinical features of 62 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

7 January 2021

A clinicopathologic review of 25 cases of chordoma (a pleomorphic and metastasizing neoplasm).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

7 January 2021

Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

7 January 2021

Skull base and nonskull base chordomas: clinicopathologic and immunohistochemical study with special reference to nuclear pleomorphism and proliferative ability

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

7 January 2021

Alterations of G1-S checkpoint in chordoma: the prognostic impact of p53 overexpression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

7 January 2021

Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

7 January 2021

Chromosome 7 abnormalities are common in chordomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

7 January 2021

Identification of isochromosome 1q as a recurring chromosome aberration in skull base chordomas: a new marker for aggressive tumors?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23141

7 January 2021

Identifiers

DOI

10.1002/CNCR.23141

1 reference

25 July 2017

1 reference